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Developmental speech and language disorders cover a wide range of childhood conditions with overlapping
but heterogeneous phenotypes and underlying etiologies. This characteristic heterogeneity hinders accurate
diagnosis, can complicate treatment strategies, and causes difficulties in the identification of causal factors.
Nonetheless, over the last decade, genetic variants have been identified that may predispose certain individ-
uals to different aspects of speech and language difficulties. In this review, we summarize advances in the
genetic investigation of stuttering, speech-sound disorder (SSD), specific language impairment (SLI), and
developmental verbal dyspraxia (DVD). We discuss how the identification and study of specific genes and
pathways, including FOXP2, CNTNAP2, ATP2C2, CMIP, and lysosomal enzymes, may advance our under-
standing of the etiology of speech and language disorders and enable us to better understand the relation-
ships between the different forms of impairment across the spectrum.
Open access under CC BY license.Speech and Language Disorders
Developmental disorders of communication represent one of the
most common reasons for pediatric referrals (Harel et al., 1996)
and account for a large proportion of statements of educational
need (Law et al., 2000). This clinical category includes many
individuals in whom speech and language problems are symp-
tomatic of a more global developmental condition, such as
autistic spectrum disorder, learning disability, or hearing impair-
ment. For others, the speech and language deficit occurs in an
otherwise normal developmental trajectory and has no obvious
cause (Bishop, 1994). Such primary speech and language disor-
ders are currently classified into five distinct categories: expres-
sive language disorder, mixed receptive-expressive language
disorder, phonological disorder, stuttering, and communication
disorder not-otherwise-specified (DSM-IV). Disorders of speech
involve an impairment in the production of fluent and compre-
hensible speech and include stuttering, in which the fluency of
speech is disrupted; phonological disorder (including speech-
sound disorder [SSD]), in which the problem lies in the produc-
tion and proper use of speech sounds; and developmental verbal
dyspraxia, in which there is impairment in the coordination and
motor control of the speech organs. Disorders of language are
perhaps less perceptible but no less profound. They may involve
problems with the correct formation of words (morphology) or
sentences (syntax), the derivation of meaning (semantics), or
the use of linguistic context (pragmatics) and may affect expres-
sive and/or receptive language as well as nonverbal language
(e.g., reading and writing—developmental dyslexia). The term
specific language impairment (SLI) is often used as an umbrella
term for expressive language disorder, mixed receptive-expres-
sive language disorder, and sometimes phonological disorder.
Although many of these speech and language disorders are
differentiated at a clinical level, they are highly comorbid with
each other. Many children do not fall neatly into a single diag-
nostic cluster, and others may change between categories as
their language develops. Approximately 15% of children withpersistent speech disorders also have a language disorder and
approximately 5% of children with SLI also experience speech
difficulties (Shriberg et al., 1999). Over 60% of stutterers present
with concurrent speech and language disorders, the most
common of which is articulation disorder (Blood et al., 2003).
Furthermore, although the diagnostic criteria for SLI necessi-
tates the absence of explanatory medical conditions, studies
have found that affected individuals are at an increased risk of
associated developmental delays, cognitive impairment, social
problems, literacy deficits, and behavioral difficulties (Conti-
Ramsden and Botting, 1999; Conti-Ramsden et al., 2001; Law
et al., 2000; Wadman et al., 2008). The exact relationship
between speech and language deficits and these other develop-
mental problems remains a matter of debate, and the etiological
basis of these overlaps are unclear.
It is well documented that genetic factors contribute to
susceptibility to speech and language impairments. Speech
and language deficits are heritable and show strong familial
aggregation (e.g., Barry et al., 2007; Clark et al., 2007; Conti-
Ramsden et al., 2007; Lewis et al., 2007). Moreover, twin studies
report an increase in monozygotic twin concordance rates over
that of dizygotic twins, suggesting that much of this aggregation
can be attributed to genetic influences (Bishop, 2002; Felsenfeld
et al., 2000; Hayiou-Thomas, 2008). Nonetheless, it is generally
thought that the genetic mechanisms underlying susceptibility
to speech and language disorders are multifactorial in nature,
involving complex interactions between several common
genetic variants and environmental factors. Despite this
complexity, researchers have recently begun to identify genetic
factors that may play a role in the etiology of speech and
language disorders (Kang et al., 2010; Newbury et al., 2009;
Vernes et al., 2008). It is hoped that the identification of contrib-
utory genetic risk factors will allow the elucidation of biological
pathways and neurological mechanisms that contribute to
speech and language acquisition processes and play a critical
role in the etiology of speech and language disorders. In turn,Neuron 68, October 21, 2010 ª2010 Elsevier Inc. 309
Neuron
Reviewthe investigation of identified genetic factors may help untangle
the complex relationships between speech and language disor-
ders and related developmental conditions.
In this review, we provide an overview of recent developments
in the genetic study of spoken developmental speech and
language disorders. We do not describe the study of develop-
mental dyslexia as excellent reviews of this area have recently
been published (Scerri and Schulte-Ko¨rne, 2010).
Methods for Identifying Contributory Genetic Variants
For some genetic disorders, it is possible to select candidate
genes on the basis of their function alone. However, for speech
and language disorders, in which the underlying biological
mechanism is unclear, the identification of susceptibility genes
usually starts with an unbiased screening approach. This step
allows the identification of a candidate region and thus acts to
reduce the number of possible contributory genes to a manage-
able size prior to a more in-depth investigation. These screening
approaches usually take the form of genome-wide linkage or
association studies (Elston and Anne Spence, 2006).
In a linkage study, one investigates families with members
affected by the disorder under study. By genotyping polymor-
phic genetic markers spread across the genome, it is possible
to generate measures of genetic identity between sibling pairs.
Linkage studies look for regions of the human genome in which
there is a correlation between the level of genetic identity and the
level of phenotypic similarity for any given sib pair. Perhaps the
most simple example of linkage analysis is provided by the study
of single-gene disorders in large families. In such circumstances,
one is able to identify specific chromosome segments that cose-
gregate with disease status between affected relative pairs.
Nonetheless, as discussed below, the study of such pedigrees
in complex disorders is the exception rather than the rule.
Instead, the majority of linkage studies for complex disorders
investigate large numbers of smaller nuclear families and
compare genetic identity between sibling pairs within family
units. Such analyses can be performed under the assumption
of a defined genetic model (parametric linkage analysis) or by
using a model-free method (nonparametric linkage analysis).
Linkage analyses provide a robust and powerful method of
detecting contributing genetic factors but afford a low level of
resolution. Thus, although linkage studies can be completed
with relatively small sample sizes, they often lead to the identifi-
cation of large genetic intervals, which necessitate follow-up
higher-resolution (targeted association) investigations to allow
the identification of a specific candidate gene. Linkage studies
are usually completed at a genome-wide level (i.e., across all
chromosomes—i.e., a genome-wide linkage analysis or GWLA)
but may target specific chromosome regions (targeted linkage)
if the researcher has an a priori reason to do so.
Because linkage studies simply investigate the level of genetic
sharing (joint inheritance), they do not allow the identification of
specific contributory genetic variants. For this crucial step, an
association study is required. In contrast to linkage, an associa-
tion study is based upon the principle that contributory genetic
variants will bemore common in affected (cases) than unaffected
(controls) individuals. In the simplest example, if a given genetic
variant was necessary and sufficient for the onset of the disorder310 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.then wewould expect this variant to be present in 100%of cases
but never in controls. In complex disorders, the effect is not
expected to be so stark but the rationale still holds. Association
studies provide a better resolution of genetic information than
linkage studies but are not as powerful and necessitate the
genotyping of a high number of genetic markers in extremely
large samples. These factors bring their own complications in
terms of the logistics of data generation and multiple testing
issues. Nonetheless, it is now possible to routinely generate
genotypes for 2.5 million genetic variants (single-nucleotide
polymorphisms [SNPs]) in thousands of case and control individ-
uals enabling a so-called genome-wide association (GWA)
study. The fact that association models were developed for
case-control cohorts means that they often do not provide
a convenient method for the fine mapping of linkage peaks in
family-based samples. However, it is possible to apply such
methods to genetic data collected from families by using parents
or unaffected siblings as controls (Lunetta et al., 2000) or by
applying quasi-association extensions (Abecasis et al., 2000).
Such methods provide an important solution to fine mapping
and the investigation of quantitative traits and may offer
increased power to detect etiological variants.
It should be noted that although association studies are theo-
retically capable of identifying specific causal variants with rela-
tively low effect sizes, in practice the genetic variants identified
by association studies are not necessarily functional. Instead,
they tend to be proxies that mark the approximate position of
the etiologic genetic variant within a small segment of DNA.
Thus, while association studies provide a strong starting point
for functional studies, even high-density SNP association
screens will require follow-up investigations to enable proof of
causality (McCarthy and Hirschhorn, 2008).
Linkage and association investigations of speech and
language disorders followed on from similar investigations of
the related disorder developmental dyslexia in the 1990s (Scerri
and Schulte-Ko¨rne, 2010). Over the last decade, researchers of
speech-sound disorder have applied targeted linkage studies,
while investigators of SLI and stuttering have performed
genome-wide linkage studies and subsequent targeted associa-
tion studies. In addition, a rare and specific form of verbal
dyspraxia has been attributed to mutations of a specific gene
known as FOXP2. A summary of loci that have been implicated
in these various speech and language disorders, as well as
particular genes that have been identified, is provided in Table 1.
FOXP2
The first gene to be implicated in a speech and language disorder
was identified by the investigation of a large family affected by
a distinctive form of speech impairment known as verbal
dyspraxia. Verbal dyspraxia is characterized by difficulties in
the control of orofacial muscles leading to a deficit in the produc-
tion of fluent speech. In addition to their speech problems,
affected members of this family also had expressive and recep-
tive language deficits and, in some cases, written language
problems and nonverbal cognitive impairment (Watkins et al.,
2002). The remarkable thing about the speech and language
impairments observed in this family was that the pattern of inher-
itance indicated that theymaybe causedby amutation in a single
gene (Vargha-Khadem et al., 1995). Genome-wide linkage
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and fine mapping of the locus indeed identified a mutation in the
FOXP2 gene (OMIM 605317) that was present in all affected
family members but not in unaffected individuals (Lai et al.,
2001). The relevance of FOXP2 mutations to other cases of
verbal dyspraxia was supported by the identification of an unre-
lated child with a similar form of speech impairment who was
found to have a chromosome rearrangement that disrupted the
FOXP2 gene (Lai et al., 2001). These data have since been
confirmed by several independent FOXP2 screening studies
that have identified additional individuals with disruptions of
this gene, all of whom have syndromes that feature verbal
dyspraxia (Feuk et al., 2006; Lai et al., 2000; Lennon et al.,
2007; MacDermot et al., 2005; Pariani et al., 2009; Shriberg
et al., 2006; Tomblin et al., 2009; Zeesman et al., 2006). The
FOXP2 gene encodes a winged helix/forkhead DNA-binding
protein from the FOX family. This protein acts as a transcriptional
repressor and has four alternative isoforms (Bruce and Margolis,
2002; Lai et al., 2001; Schroeder and Myers, 2008). The FOXP2
gene shows a widespread pattern of expression across the
majority of tissues and developmental time points. Nonetheless,
within each tissue its expression appears to be tightly regulated
in a complex pattern of expression with a high degree of conser-
vation across species (Ferland et al., 2003; Lu et al., 2002;
Schroeder and Myers, 2008; Shu et al., 2001, 2007).
The identification of FOXP2 opened up a whole field of
research encompassing a wide range of disciplines including
neuroimaging, animal models (primarily mouse and songbird),
molecular studies of gene function and expression, and popula-
tion and evolutionary studies (reviewed in Fisher, 2006; Fisher
and Scharff, 2009). Although the exact role of FOXP2 in the
cause of verbal dyspraxia has yet to be elucidated, it is clear
that this gene is of particular importance in the development of
brain regions responsible for fine motor control (motor cortex,
striatum, and cerebellum) and that its disruption has exception-
ally severe consequences for the development of speech. Many
detailed reviews of FOXP2 have been previously published and
we refer the reader to these for a more in-depth discussion of
this gene (Fisher, 2006; Fisher and Scharff, 2009).
Despite its obvious importance in severe and rare forms of
verbal dyspraxia, it seems increasingly unlikely that FOXP2
represents a general risk factor for genetically complex forms
of language impairment (Meaburn et al., 2002; Newbury et al.,
2002; O’Brien et al., 2003), nor is it expected to play a role in
the related disorder autism (Gauthier et al., 2003; Laroche
et al., 2008; Li et al., 2005; Marui et al., 2005; Wassink et al.,
2002). However, the identification of this gene heralded a new
era for the genetic study of speech and language as it allowed
the identification of some of the biological pathways and mech-
anisms important for speech and language acquisition
processes. Since FOXP2 is a transcription factor, it regulates
the expression of other genes, some of which may be expected
to be involved in more common forms of speech and language
deficits. Gene-targeting screens indicate that the FOXP2 protein
is responsible for the downregulation of between 300 and 400
neural genes, many of which functionally represent good candi-
date genes for speech and language disorders (Spiteri et al.,
2007; Vernes et al., 2007).CNTNAP2
The list of genes regulated by FOXP2 includes a gene on
chromosome 7 known as CNTNAP2 (OMIM 604569) (Spiteri
et al., 2007; Vernes et al., 2007). Recent evidence indicates
that this gene may play a role in susceptibility to genetically
complex forms of language impairment (Vernes et al., 2008).
This study found that nine common genetic variants, involving
changes at single base pairs (single-nucleotide polymorphisms)
across the CNTNAP2 sequence, were significantly correlated
(minP = 5.03 105) with reduced performance across a number
of linguistic measures (expressive and receptive language and
phonological short-term memory) in a cohort of language-
impaired families (Vernes et al., 2008). The mechanism by which
these SNPs might alter CNTNAP2 function has yet to be eluci-
dated, and these findings have yet to be replicated in additional
language-impaired samples. However, alternative variations
across this gene (including common variation and rare disrup-
tions ormutations) have also been implicated in a range of neuro-
developmental disorders including autism (Alarco´n et al., 2008;
Arking et al., 2008; Bakkaloglu et al., 2008; Jackman et al.,
2009; Poot et al., 2010; Rossi et al., 2008), Gilles de Tourette
syndrome (Belloso et al., 2007; Verkerk et al., 2003), schizo-
phrenia (Friedman et al., 2008; O’Dushlaine et al., 2010), epilepsy
(Friedman et al., 2008; Mefford et al., 2010; Strauss et al., 2006),
ADHD (Elia et al., 2010), and learning disability (Zweier et al.,
2009). Furthermore, CNTNAP2 variation has also been associ-
ated with the normal personality trait ‘‘openness to experience’’
(Terracciano et al., 2010).
CNTNAP2 encodes a neurexin protein that is responsible for
the localization of potassium channels in developing neurons
and plays an important role in the facilitation of axonal-glial inter-
actions (Poliak et al., 2003; Zweier et al., 2009). Brain expression
studies indicate that while this gene is evenly expressed across
the rodent brain, it shows a specific pattern of expression in the
song control nuclei of male songbirds (Panaitof et al., 2010) and
is enriched in the frontal cortex of humans (Abrahams et al.,
2007). Structural MRI studies of population cohorts found that
individuals who carry two copies of the genetic ‘‘risk’’ variants
previously associated with autistic disorder have significantly
reduced volumes of gray and white matter across several brain
regions, including the prefrontal cortex, fusiform gyri, occipital
cortices, and cerebellum, which have previously been shown
to be important in autistic disorder (Tan et al., 2010).
Thus current data suggest thatCNTNAP2 plays a fundamental
role in neuronal development and that perturbations of its func-
tion may contribute to susceptibility to a diverse range of neuro-
developmental psychiatric disorders as well as normal variations
in brain function (Corvin, 2010).
FOXP1
On the basis of FOXP2 data, researchers have suggested that
other forkhead binding genes represent good candidates for
involvement in speech and language impairments. The human
FOX gene family consists of over 40 members classified into
19 subfamilies (designated FOXA to FOXS) according to specific
motifs within the DNA binding domain (Hannenhalli and Kaest-
ner, 2009). The FOXP subfamily includes four genes (FOXP1-4)
with diverse functions. The proteins encoded by these genes
are found to bind to each other to form active heterodimerNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 311
Table 1. Summary of Loci Implicated in Speech and Language Disorders
Chromosome
Region Gene Disorder
Gene Identification
Method
Identification
References
Replication
Notes
1p NA Speech-sound disorder Targeted linkage Miscimarra et al. (2007) Region also linked to
dyslexia
1q NA Stuttering GWLA Riaz et al. (2005)
2q NA Stuttering GWLA Suresh et al. (2006) Replicated by Wittke-
Thompson et al. (2007)
3 NA Speech-sound disorder Targeted linkage Stein et al. (2004) Region also linked to
dyslexia
3p14 FOXP1 Developmental delay
with speech and
language impairment
Translocation mapping
and chromosome
abnormality screen
Pariani et al. (2009); Carr
et al. (2010); Horn et al.
(2010); Vernes et al.
(2009)
Replicated across
several individuals with
variable phenotypes
3q NA Stuttering GWLA Wittke-Thompson et al.
(2007)
Linkage to 3q also found
by Raza et al. (2010)
5q NA Stuttering GWLA Riaz et al. (2005) Replicated by Wittke-
Thompson et al. (2007)
6p NA Speech-sound disorder Targeted linkage Smith et al. (2005) Region also linked to
dyslexia
7q31 FOXP2 Verbal dyspraxia GWLA with subsequent
translocation mapping in
an unrelated affected
individual
Fisher et al. (1998); Lai
et al. (2001)
Disrupted in a small no. of
individuals with verbal
dyspraxia. Not
associated with SLI or
autism.
7q NA Stuttering GWLA Riaz et al. (2005) Replicated by Suresh
et al. (2006) in male
individuals only
7q36 CNTNAP2 SLI Targeted association of
candidate gene
Vernes et al. (2008) Also associated with
a range of other
neurodevelopmental
disorders. Association
with SLI yet to be
replicated.
9p NA Stuttering GWLA Suresh et al. (2006)
12q23 GNPTAB Stuttering GWLA and subsequent
targeted candidate gene
sequencing
Kang et al. (2010); Riaz
et al. (2005)
Linkage replicated by
Suresh et al. (2006) when
conditioning on chr 7q
stuttering locus
13 NA SLI GWLA Bartlett et al. (2002) Replicated by Bartlett
et al. (2004)
13q NA Stuttering GWLA Wittke-Thompson et al.
(2007)
Overlaps with Bartlett
linkage to SLI
15p NA Stuttering GWLA Suresh et al. (2006)
15q NA Stuttering GWLA Wittke-Thompson et al.
(2007)
15q NA Speech-sound disorder Targeted linkage Smith et al. (2005) Region also linked to
dyslexia. Replicated by
Stein et al. (2006)
16p13 GNPTG Stuttering Targeted candidate gene
sequencing
Kang et al. (2010)
16p13 NAGPA Stuttering Targeted candidate gene
sequencing
Kang et al. (2010)
312 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.
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Table 1. Continued
Chromosome
Region Gene Disorder
Gene Identification
Method
Identification
References
Replication
Notes
16q24 ATP2C2 SLI GWLA and subsequent
targeted association
Newbury et al. (2009);
SLIC (2002)
Linkage replicated by
Falcaro et al. (2008);
Monaco (2007); SLIC
(2004). Association with
SLI yet to be replicated.
ATP2C2 associated with
ADHD (Lesch et al., 2008)
16q24 CMIP SLI GWLA and subsequent
targeted association
Newbury et al. (2009);
SLIC (2002)
Linkage replicated by
Falcaro et al. (2008);
Monaco (2007); SLIC
(2004). Association with
SLI yet to be replicated.
18p NA Stuttering GWLA Shugart et al. (2004)
19q13 NA SLI GWLA SLIC (2002) Linkage replicated by
Falcaro et al. (2008;
Monaco (2007); SLIC
(2004).
21p NA Stuttering GWLA Suresh et al. (2006) Linkage in female
individuals only
GWLA, genome-wide linkage analysis; SLI, specific language impairment.
Neuron
ReviewDNA binding molecules (Li et al., 2004, 2007). In particular, it has
been suggested that FOXP1 and FOXP2 may have a particularly
close relationship with overlapping functions that allow them to
work in a cooperative manner during tissue development (Shu
et al., 2007). In 2009, Pariani et al. described a patient with a dele-
tion of chromosome 3 that disrupted the FOXP1 gene and
deleted three other transcripts (EIF4E3, GPR27, and PROK2).
The primary clinical presentation was described as blepharophi-
mosis (drooping eyelids) and arthrogryposis (contractures of
hands and feet). However, the child also presentedwith develop-
mental delays and speech and language deficits, which the
authors hypothesized might be caused by the disruption of
FOXP1 (Pariani et al., 2009). A subsequent sequencing screen
of the FOXP1 coding sequence in 49 probands with a clinical
diagnosis of developmental verbal dyspraxia described a nonsy-
nonymous coding change that was observed in a single proband
(Vernes et al., 2009). However, a similar change was also docu-
mented in an unaffected control individual (Vernes et al., 2009).
More recently, a study described a patient with a Chiari I malfor-
mation (cerebellar tonsil abnormality) and epileptiform
discharges with periods of motor arrest (Carr et al., 2010). This
child was initially referred because of concerns over speech
delay and was found to have a deletion involving only the
FOXP1 gene (Carr et al., 2010). Although the clinical presentation
of this patient differed considerably from that observed by
Pariani et al., the authors suggest that the blepharophimosis
and arthrogryposis in the former case may be caused by the
deletion of additional transcripts. They go on to surmise that
the FOXP1 disruptions are likely to account for the similarities
in patient phenotype, namely deficits in motor development
and speech delays. This hypothesis has recently gained support
from a large-scale study for chromosome abnormalities in 1523
individuals with learning disability (Horn et al., 2010). This inves-tigation identified deletions of the FOXP1 gene in three unrelated
patients (two males, one female) with moderate learning
disabilities, global developmental delays, and severe speech
and language disorders. MRI and electroencephalography of
the patients did not reveal any gross structural brain abnormali-
ties, and a similar chromosome deletion was again observed in
a control individual who was not reported to have learning
difficulties.
The above studies illustrate the difficulties of correlating
genetic variation with specific phenotypic features. Even in
cases where a sequence disruption can be definitively demon-
strated across a number of individuals, the proof of causality is
not always straightforward. While it is true that all of the above
cases had severe speech and language difficulties, these
impairments often formed part of a more global developmental
delay that was not necessarily consistent across individuals. In
addition, control individuals with no reported developmental
problems were also found to carry disruptions of the FOXP1
sequence. Furthermore, FOXP1 has also been associated with
the skin disorder vitiligo (Jin et al., 2010), host-response to
hepatitis vaccines (Davila et al., 2010), and the likelihood of
cancer survival (Fox et al., 2004; Jais et al., 2008). The diversity
of these data are typical and by no means insinuate that these
particular results must be spurious. Indeed, similar results have
been described by the CNTNAP2 and FOXP2 studies described
above—it is important to remember that no gene product acts in
isolation. The function of genes may vary across different devel-
opmental time points and in different tissues and are modulated
by a large number of stochastic variables that differ between
individuals. Thus, it is unlikely that any genetic investigation will
ever be able to draw a simple relationship between a given
gene and a specific outcome. Furthermore, it is entirely possible
that a transcription factor, such as FOXP1, which has theNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 313
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in many seemingly unrelated disorders. Thus, given the recent
convergence of evidence, it is likely that FOXP1 is involved in
biological processes that are particularly important in the devel-
opment of speech and language.
The function of the FOXP1 protein in the brain remains unclear,
but recent studies suggest that it may play a role in motor neuron
diversification, through its interactions with Hox proteins (Dasen
et al., 2008; Rousso et al., 2008); in neuronal migration, by gating
Reelin signaling pathways (Palmesino et al., 2010); and in
neuronal differentiation, via regulation of the Pitx3 protein
(Konstantoulas et al., 2010).
Thus the accumulation of recent data suggests that, like its
partner FOXP2, FOXP1 may also be involved in the determina-
tion of neural circuitry important for the development of speech
and language.
Speech-Sound Disorder
Aside from FOXP2, its downstream targets, and its binding
partners, researchers have reasoned that candidate genes or
genetic regions implicated in dyslexia may also represent good
candidates for speech and language disorders. This is particu-
larly true for speech-sound disorder (SSD), which is character-
ized by the substitution or emission of speech sounds leading
to intelligible speech. Speech-sound errors are a common
feature of the language acquisition process but in children with
SSD persist beyond the appropriate developmental time point.
For example, it is estimated that while approximately 16% of
3-year-old children use inappropriate speech-sound formations,
these errors only persist in 4% of children at 6 years of age
(Shriberg et al., 1999). Speech-sound disorder is believed to
be a specific problem with the development of phonological
awareness (i.e., the conceptualization of speech-sound units)
and, as such, of all the speech and language disorders is
proposed to share the greatest etiological overlap with develop-
mental dyslexia. In support of this theory, the presence of early
speech problems has been shown to represent a significant
risk factor for later literacy impairments, especially when the
speech problems are accompanied by additional language-
related deficits (Peterson et al., 2009; Raitano et al., 2004; Sices
et al., 2007). These similarities have led researchers of SSD to
focus entirely upon specific genetic regions that have previously
been identified by linkage studies of dyslexia, namely chromo-
somes 1p, 3, 6p, and 15q (Scerri and Schulte-Ko¨rne, 2010),
and in some cases, this approach has proved successful. Signif-
icant levels of linkage (minP = 0.00002) have been described
between chromosome 3 (DYX5, OMIM 606896) and phonolog-
ical memory and phonological decoding traits in SSD families
(Stein et al., 2004). Suggestive levels of linkage have been
reported on chromosomes 1 (DYX8, OMIM 608995) (minP =
0.0009, Miscimarra et al., 2007) 6 (DYX2, OMIM 600202)
(minP = 0.0006, Smith et al., 2005), and 15 (DYX1, OMIM
127700) (minP = 0.004, Smith et al., 2005). An additional study
found linkage to a binary affection status of SSD and quantitative
measures of oral motor control, articulation, and phonological
short-termmemory in a region that flanked the DYX1 locus (Stein
et al., 2006, 15 Mb distal). This region has previously been impli-
cated in autism (AUTS4, OMIM 608636) and is commonly314 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.deleted in Prader-Willi Syndrome (Cook et al., 1998). It is
possible that this result may represent variations in the precise
positions of peaks of linkage, which may be caused by differ-
ences in genetic structure, or it may be that there are two loci
on chromosome 15 that contribute to SSD etiology, one of which
overlaps with the autism locus and a second of which coincides
with DYX1.
Recent targeted association studies in dyslexic families have
led to the identification of specific candidate genes within the
dyslexia linkage loci mentioned above (reviewed in Scerri and
Schulte-Ko¨rne, 2010). Intriguingly, many of these genes have
functions in neuronal migration, a critical step in cortex develop-
ment (reviewed by Gabel et al., 2010). These data complement
the findings of classical postmortem neuroanatomical studies
of dyslexic individuals (Galaburda et al., 1985) and suggest
that this process may play a role in the etiology of reading disor-
ders. The direct evaluation of these specific risk variants in SSD
populations would categorically provide an answer to the ques-
tion regarding etiological overlaps between these two disorders.
Specific Language Impairment
In contrast to SSD, investigations of SLI have applied a genome-
wide linkage approach to the identification of candidate genes or
regions. SLI is diagnosed as an unexpected disorder in the
acquisition of language despite adequate intelligence and
opportunity and in the absence of any explanatory medical
conditions (e.g., autism or hearing impairment) (Law et al.,
2000). By definition, SLI is a very heterogeneous disorder that
includes disorders of speech that have no obvious motoric
etiology and incorporates deficits in other areas of expressive
language (e.g., grammar, syntax, and semantics) as well as
impairments in receptive linguistic abilities.
Two whole-genome linkage screens have been performed
identifying three primary sites of linkage toSLI. These areon chro-
mosome 13 (SLI3, OMIM 607134) (Bartlett et al., 2002), 16 (SLI1,
OMIM 606711) (SLIC, 2002), and 19 (SLI2, OMIM 606712) (SLIC,
2002). These studies both involved relatively small numbers of
affected families and yielded borderline significant p values.
Nonetheless, of all the linkagedata presented in this review, these
three loci probably represent the strongest and most developed
results as they have all been confirmed by subsequent replication
and fine-mapping studies (Bartlett et al., 2004; Falcaro et al.,
2008; Monaco, 2007; SLIC, 2004). The SLI1 region on chromo-
some 16 has been subject to the most in-depth investigation,
and a targeted association study recently enabled the identifica-
tion of specific genetic variants that may cause linkage to this
locus (Newbury et al., 2009). Significant associationwas identified
to two distinct clusters of commongenetic variants locatedwithin
theATP2C2 gene (OMIM613082,minP = 23 105) and theCMIP
gene (OMIM 610112, minP = 63 107). Variation in both of these
genes was predominantly associatedwith performance on a task
of phonological short-termmemory, supporting the importanceof
memoryprocesses in languageacquisition (Newbury et al., 2009).
Regression modeling indicated that ATP2C2 and CMIP exerted
an independent effect upon phonological memory ability, sup-
porting a role for both regions in language ability. Within this tar-
geted association study, a marginally significant, similar trend of
association was observed to ATP2C2 (minP = 0.006) in a sample
Neuron
Reviewof low-language performers selected from a population cohort.
Thus, although this is perhaps the most thoroughly investigated
locus described in this review, these results still require external
replication, and a functional variant or mechanism has yet to be
identified. Little is known regarding the functions of the CMIP
and ATP2C2 proteins in the brain but both represent reasonable
candidates. ATP2C2 encodes a calcium ATPase responsible for
the regulation of cellular calcium andmanganese levels. Calcium
is an important intracellular messenger and is involved in many
neuronal processes including short-term memory (Dash et al.,
2007).Manganese ions are toxic to neuronal cells at high concen-
trations (Perl and Olanow, 2007), and manganese deficiency is
linked with epilepsy (Carl et al., 1986). CMIP was identified
through a screen to identify large proteins expressed in the brain
(Nagase et al., 2000) and encodes an adaptor protein thought to
form part of the cytoskeleton (Grimbert et al., 2003). Cytoskeletal
remodeling plays a key role in synaptic formation and neuronal
migration (Heng et al., 2010). The CMIP protein has been shown
to interact with FilaminA (Grimbert et al., 2004), mutation of which
is associated with the neuronal migration disorder X-linked
periventricular heterotopia (OMIM 300017). Other studies have
found that it also interactswith theRelA (a subunit of the transcrip-
tion factor NF-kappaB) (Kamal et al., 2009) and PI3 kinase
proteins (Kamal et al., 2010), indicating that, as described for
the FOX proteins above, CMIP may function across multiple
biological pathways. Neither CMIP nor ATP2C2 was identified
as a FOXP2 target (Spiteri et al., 2007; Vernes et al., 2007), and
no obvious relationships can be formulated between the two
genesorwith that of theCNTNAP2gene, indicating that the follow
up of these datamay implicate newpathways and processes that
are important for the development of language. Interestingly,
variants within ATP2C2 have been associated with attention
deficit hyperactivity disorder (ADHD, Lesch et al., 2008) indicating
that the pleiotropic effects described for other language loci may
also extend to this region.
In addition to the genome-wide approaches described above,
one group has specifically investigated dyslexia-linked loci and
the FOXP2 region of chromosome 7 in language-impaired
families (Rice et al., 2009). This study found a suggestive level
of linkage to variants across all regions investigated on chromo-
somes 1 (DYX8), 3 (DYX5), 6 (DYX2), 7 (FOXP2), and 15 (DYX1),
with various measures of linguistic ability. Association analyses
of a denser panel of variants across FOXP2 and KIAA0319
revealed a marginal level of association (minP = 0.01) between
KIAA0319 and measures of speech, language, and reading
and between FOXP2 and reading, language, and articulation
(Rice et al., 2009), indicating that the behavioral effects of these
genes may extend across related phenotypes. This study further
supports the etiological relationships between dyslexia and
speech and language disorders, as suggested by the SSD inves-
tigations described above.
Stuttering
The potential of founder and consanguineous pedigrees has
recently been demonstrated by the identification of genetic path-
ways that may be important in the etiology of stuttering. Stutter-
ing is defined as a disorder of speech fluency characterized by
interruptions in speech flow and involuntary repetition or elonga-tion of syllables (Prasse and Kikano, 2008). This disorder is
relatively distinct from SSD and SLI and is persistent in approx-
imately 20% of cases, particularly males (Prasse and Kikano,
2008). The majority of molecular genetic studies of stuttering
have focused upon large consanguineous pedigrees in which
stuttering appears to be familial and persistent. Four genome-
wide linkage and one genome-wide association study have
been performed for persistent familial stuttering. These investi-
gations have yielded suggestive linkage to chromosomes 2, 3,
5, 7, 9, 12, 15, 18, and 21 and indicate a strong but complex
sex effect in the relationships between risk variants (Raza
et al., 2010; Riaz et al., 2005; Shugart et al., 2004; Suresh
et al., 2006; Wittke-Thompson et al., 2007). Nonetheless, these
studies yielded only moderate evidence of linkage or association
to any one region, and the overlaps between the results were
sparse. The most consistent and significant region implicated
is on chromosome 12q (STUT2, OMIM 609261) (Riaz et al.,
2005; Suresh et al., 2006). Sequencing of 45 genes across
STUT2 revealed four coding mutations in the GNPTAB gene
that were present in significantly more affected family members
than unaffected individuals (Kang et al., 2010) TheGNPTAB gene
(OMIM 607840) encodes subunits of the N-acetylglucosamine-
1-phosphotransferase enzyme, which plays a role in lysosomal
targeting processes. An additional subunit of this enzyme is
encoded by the GNPTG gene (OMIM 607838) on chromosome
16p and a downstream enzyme, N-acetylglucosamine-1-phos-
phodiester alpha-N-acetylglucosaminidase is encoded by the
NAGPA gene on chromosome 16p (OMIM 607985). Sequencing
of these related transcripts revealed additional coding mutations
that were not observed in control individuals (Kang et al., 2010).
Across the GNPTAB, GNPTG, and NAGPA genes, mutations
were observed in 3.2% of the case chromosomes and 0.5% of
the control chromosome screened (Kang et al., 2010). This study
therefore implicates an additional biological mechanism in
speech disorders—that of the lysosomal enzyme pathway.
Mutations in the GNPTAB and GNPTG genes have previously
been described to cause the metabolic disorders mucolipidosis
types II and III, respectively (OMIM 252500 and 252605)
(Paik et al., 2005; Raas-Rothschild et al., 2000). These disorders
are not characterized by stuttering but instead by skeletal abnor-
malities, restricted joint movement, and disorders of the heart,
liver, and spleen. In some cases (particularly type II), these
features are accompanied by developmental delay and speech
problems but not typically stuttering. However, none of the
mutations identified by Kang et al. were identical to those that
had previously been implicated in mucolipidosis. Furthermore,
since mucolipidosis is a recessive disorder, affected individuals
must carry two copies of a mutation. In the stuttering cohort, all
but two individuals carried one normal copy of the GNPTAB and
GNPTG gene. This may therefore account for the less severe
phenotype described in this sample. This intriguing study has
yet to be replicated or extended and there are many interesting
questions that can be asked regarding the mechanism of
susceptibility to stuttering in these individuals.
Conclusions
In summary, the last decade has seen an explosion in our under-
standing of the genetic basis of speech and language disorders.Neuron 68, October 21, 2010 ª2010 Elsevier Inc. 315
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that continues to advance our understanding of the foundations
of speech and language. It is likely that in the future, the investi-
gation of the pathways that involve and intersect with FOXP2will
identify many more candidate genes and mechanisms under-
lying speech and language disorders. The investigation of SSD
has indicated that this disorder may share some genetic basis
with developmental dyslexia. The study of SLI has enabled the
identification of two candidate genes on chromosome 16
(ATP2C2 and CMIP), and stuttering research has identified the
lysosomal enzyme pathway (GNPTAB, GNPTG, and NAGPA)
as another candidate mechanism.
Although the recent progress in this field is promising, it should
be noted that, in comparison to other developmental disorders
with a genetic contribution, speech and language disorders are
relatively understudied. Many of the studies described above
involved relatively small samples and have yet to be replicated
in independent cohorts. As genetic technologies develop, the
generation of larger data sets becomes progressively easier,
allowing the identification of genetic variants with smaller effect
sizes. Nonetheless, the application of these technologies
demands the existence of large sample sets with consistent
ascertainment and assessment standards. Even then, as we
have seen above, and as evidenced bymany other GWA studies,
the interpretation of findings is far from straightforward. GWA
studies in other complex disorders have enabled a revolution
in candidate gene identification, but it is estimated that these
loci still only account for a small proportion of the observed
familial clustering. The source of this so-called ‘‘missing herita-
bility’’ is still a matter of debate but has been suggested to arise
from the presence of common genetic variation with minimal
effect sizes, rare variants, structural deviations, and genetic
modifications and interactions that are not well characterized
by currently available GWA technology or algorithms (Manolio
et al., 2009).
Thanks to advances in technology, however, alternative meth-
odologies are now available to complement the GWA. It is now
feasible to directly sequence entire genomes for increasingly
large sample sizes, and this will be important in the identification
of rare mutations (Cirulli and Goldstein, 2010). It is also now
recognized that successful GWAs rely upon adequate sample
sizes and precise phenotyping, and to achieve this, meta-anal-
yses may be required. Improved sample sizes and the investiga-
tion of alternative populations both afford increased power to
detect variants with smaller effect sizes and enable the investiga-
tion of gene-gene interaction effects (Manolio et al., 2009).
In addition, the genome-wide investigation of epigenetic effects
may identify alternative sources of genetic variation that are not
readily captured by the GWA approach (Maunakea et al., 2010).
It is envisaged that these advanceswill facilitate the identification
of greater numbers of risk variants, and this is reflected in the
current trend away from the identification of ‘‘disease genes’’
toward an understanding of the biological pathways that underlie
specific pathologies. Given this appetite for ever-larger data
sets, it is perhaps ironic that the gene that has provided us
with the most information regarding speech and language disor-
ders was identified by the investigation of a single family with
a rare and specific form of speech impairment. The FOXP2 story316 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.demonstrates the continuing validity of the genetic approach
and exemplifies how such data can be used to complement
and inform larger genome-wide and biological pathway investi-
gations.
Through this review, we hope not only to have summarized the
findings of genetic investigations of speech and language disor-
ders but also to have indicated the challenges faced during the
genetic investigation of such disorders. As genetic throughput
expands, the true challenge is not the generation of data but
the interpretation of the findings and the proof of causality.
It will be interesting to see whether the recent findings pertaining
to speech and language disorders can be replicated and how
these avenues of investigation will eventually combine with those
generated from larger high-throughput studies. Ultimately, it is
hoped that the research summarized in this paper will allow
a better understanding of the causes of speech and language
disorders and the complex relationships between these impair-
ments, thereby facilitating better diagnostic and treatment
schedules for affected individuals.ACKNOWLEDGMENTS
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